EAE suppression caused by Δ-8-THC treatment is due to downregulation of CNS infiltrating CD4+ T-cells, proinflammatory cytokines and apoptotic genes expression

khadija kakar,Prakash Nagarkatti,mitzi nagarkatti
DOI: https://doi.org/10.4049/jimmunol.208.supp.60.10
2022-05-01
The Journal of Immunology
Abstract:Abstract Δ-8-THC a naturally occurring cannabinoid found in trace amounts in Cannabis plants. It possesses potent anti-inflammatory properties along with several other medical benefits. Δ-8-THC has been shown to induce immune system homeostasis particularly in individuals with autoimmune disorders by reducing the activity of T cells and B cells. In current study, we used the experimental model of MS to better understand how Δ-8-THC suppresses neuroinflammation in immune cell-mediated disease called experimental autoimmune encephalomyelitis (EAE). Δ-8-THC administration reduced significantly the clinical severity score with an increase in body weight by suppression of Th17 cells. In the CNS, there was decreased expression of pro-inflammatory cytokine IL-17, an increase in brain infiltrating CD4+ T cells and B cells, while anti-inflammatory phenotype such as FoxP3 was perturbed. Based on preliminary miRNA sequencing data and in silico examination of differential expression of miRNAs, we found that the decrease in neuroinflammation following treatment may be due to up-regulation of miRs, mmu-miR-129–3p, mmu-miR-129-5p, mmu-miR-125-5p and mmu-miR-193-3p as well as down-regulation of mmu-miR-21-3p, mmu-miR-142-5p and mmu-miR147-3p in immune cells in the CNS. Target genes were predicted by TagetScan, miRbase, miRDB. The target genes associated with upregulated miRs included Hrk, CHMP2b, Arid3a and Dcaf7 which are mostly involved in apoptosis, autophagy and migration, while genes associated with down-regulated miRNAs were Abi2, ZFPM2, NDUFA4 that are mostly involved in cell growth, proliferation and differentiation. In summary, Δ-8-THC treatment may offer novel strategies for treatment of neuroinflammation by targeting miRs. Supported by NIH P01AT003961, P20GM103641, R01AI129788, R01 ES030144, R01 AI160896 and R01AI123947
immunology
What problem does this paper attempt to address?